Universe Pharmaceuticals (UPC) Equity Average (2021 - 2025)
Universe Pharmaceuticals' Equity Average history spans 4 years, with the latest figure at $14.0 billion for Q3 2024.
- For Q3 2024, Equity Average fell 55.74% year-over-year to $14.0 billion; the TTM value through Sep 2024 reached $14.0 billion, down 55.74%, while the annual FY2024 figure was $14.0 billion, 55.74% down from the prior year.
- Equity Average for Q3 2024 was $14.0 billion at Universe Pharmaceuticals, down from $31.7 billion in the prior quarter.
- Across five years, Equity Average topped out at $31.7 billion in Q3 2023 and bottomed at $33.9 million in Q3 2021.
- The 4-year median for Equity Average is $15.8 billion (2022), against an average of $15.8 billion.
- The largest annual shift saw Equity Average soared 52082.92% in 2022 before it crashed 55.74% in 2024.
- A 4-year view of Equity Average shows it stood at $33.9 million in 2021, then skyrocketed by 52082.92% to $17.7 billion in 2022, then surged by 78.93% to $31.7 billion in 2023, then plummeted by 55.74% to $14.0 billion in 2024.
- Per Business Quant, the three most recent readings for UPC's Equity Average are $14.0 billion (Q3 2024), $31.7 billion (Q3 2023), and $17.7 billion (Q3 2022).